Abstract
Since the discovery of the mitochondrial ATP-sensitive potassium channel (mitoKATP) more than 13:years ago, it has been implicated in the processes of ischemic preconditioning (IPC), apoptosis and mitochondrial matrix swelling. Different approaches have been employed to characterize the pharmacological profile of the channel, and these studies strongly suggest that cellular protection well correlates with the opening of mitoKATP. However, there are many questions regarding mitoKATP that remain to be answered. These include the very existence of mitoKATP itself, its degree of importance in the process of IPC, its response to different pharmacological agents, and how its activation leads to the process of IPC and protection against cell death. Recent findings suggest that mitoKATP may be a complex of multiple mitochondrial proteins, including some which have been suggested to be components of the mitochondrial permeability transition pore. However, the identity of the pore-forming unit of the channel and the details of the interactions between these proteins remain unclear. In this review, we attempt to highlight the recent advances in the physiological role of mitoKATP and discuss the controversies and unanswered questions.
Original language | English (US) |
---|---|
Pages (from-to) | 7-16 |
Number of pages | 10 |
Journal | Journal of Molecular and Cellular Cardiology |
Volume | 39 |
Issue number | 1 |
DOIs | |
State | Published - Jul 2005 |
Keywords
- Apoptosis
- Diazoxide
- Glibenclamide
- Ischemic preconditioning
- Mitochondria
- Potassium
- Reactive oxygen species
- Succinate dehydrogenase
ASJC Scopus subject areas
- Molecular Biology
- Cardiology and Cardiovascular Medicine